Skip to main content

Bottomline | The worrisome case of Aurobindo Pharma

Bottomline | The worrisome case of Aurobindo Pharma For equity investors, even a hint of suspect governance is a big red flag. It isn#39;t surprising, therefore, that the Aurobindo Pharma stock came under selling pressure on November 10 after it was reported that its Director, P Sarath Chandra Reddy, had been arrested by the Enforcement Directorate.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/bottomline-|-the-worrisome-caseaurobindo-pharma_16719151.html
Labels:

Comments

Post a Comment

Popular posts from this blog

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb
Post a Comment
Read more

Infosys partners Avaloq to strengthen wealth management capabilities via digital platforms

Infosys will be a strategic implementation partner for Avaloq#39;s wealth management suite of solutions to help clients modernize and transform their legacy systems into cutting-edge digital advisory platforms, a statement said. from Moneycontrol Business News https://ift.tt/2THaSpn
Post a Comment
Read more